| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.53B | 14.82B | 12.92B | 10.18B | 9.35B | 7.74B |
| Gross Profit | 13.73B | 17.04B | 15.29B | 10.18B | 9.35B | 7.74B |
| EBITDA | 4.67B | 9.10B | 7.38B | 5.05B | 6.01B | 1.83B |
| Net Income | 6.06B | 5.79B | 4.82B | 3.13B | 5.23B | 1.38B |
Balance Sheet | ||||||
| Total Assets | 659.82B | 631.00B | 607.17B | 592.23B | 680.04B | 451.52B |
| Cash, Cash Equivalents and Short-Term Investments | 49.19B | 50.63B | 4.16B | 20.52B | 104.28B | 51.62B |
| Total Debt | 51.17B | 77.54B | 56.76B | 50.09B | 50.74B | 94.51B |
| Total Liabilities | 622.39B | 594.14B | 570.83B | 557.97B | 644.61B | 426.24B |
| Stockholders Equity | 37.42B | 36.83B | 36.31B | 33.67B | 35.39B | 25.25B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 16.53B | 14.94B | -80.79B | 37.95B | 36.87B |
| Operating Cash Flow | 0.00 | 16.85B | 15.74B | -79.88B | 38.63B | 37.56B |
| Investing Cash Flow | 0.00 | -152.00M | 203.00M | 164.00M | 13.89B | 484.00M |
| Financing Cash Flow | 0.00 | -4.75B | 1.39B | -3.98B | 88.00M | -1.54B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | €100.84B | 9.79 | 18.66% | 4.18% | 5.66% | 8.16% | |
76 Outperform | $6.17B | 9.86 | 8.76% | 6.68% | -9.39% | 45.60% | |
75 Outperform | €64.98B | 10.97 | 15.73% | 5.02% | -7.50% | 12.76% | |
73 Outperform | £130.83B | 9.71 | 12.91% | 2.06% | -16.49% | 14.32% | |
71 Outperform | €11.80B | 11.42 | 16.71% | 4.28% | -7.12% | 15.96% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |